🔎 Trials Near Me

Gara Jalqabaatti › Kansa Selii Skwaamoo Mataa fi Morma › Utah › Salt Lake City

Qorannoo klinikaalii Kansa Selii Skwaamoo Mataa fi Morma Salt Lake City, UT keessatti

Qorannoo 11 Kansa Selii Skwaamoo Mataa fi Morma f Salt Lake City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Utah Sugarhouse Health Center, Salt Lake City
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • Farmington Health Center, Farmington · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06992427

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of Utah - Huntsman Cancer Institute, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06465069

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Huntsman Cancer Institute, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Utah Huntsman Cancer Institute, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06385080

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Namoota walitti qabaa jiraSadarkaa 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05136196

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Utah - Huntsman Cancer Institute, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05267626

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Utah Cancer Specialists, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05059444

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06330064

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Utah Cancer Specialists, Salt Lake City
  • University of Utah Health Huntsman Cancer Hospital, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT03526835

Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.

Namoota walitti qabaa jiraSadarkaa 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Gur-2026 · NCT07044635

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Utah Cancer Specialists (site 203), Salt Lake City
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Mud-2025 · NCT03556228

Qorannoo Kansa Selii Skwaamoo Mataa fi Morma magaalota biroo keessatti

Qorannoo biroo Salt Lake City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.